Spotlight on Treating Advanced Liposarcoma or Leiomyosarcoma




Watch Dr Jonathan Trent, from the Sylvester Comprehensive Cancer Center at the University of Miami, review the use of YONDELIS® for the treatment of unresectable or metastatic leiomyosarcoma and liposarcoma, 2 of the most common subtypes of soft tissue sarcoma, after an anthracycline.